Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |